• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Beckman Coulter Helping Labs Comply With Annex 1 Regulation

    FDA Clears MeMed BV Direct From Whole Blood

    Biostrap Debuts Tool to Measure Stress Resilience, Heart Rate Variability

    EndoTheia Announces Positive Study Results for Endoscopic Surgery Device

    Abbott Completes Acquisition of Bigfoot Biomedical
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Medtech’s Most Powerful M&A Drivers

    The Link Between Medtech and Connected Medical Devices

    Is the FTC Partly Responsible for Muted M&A Activity?

    Holistic Risk Management: Navigating the Future’s Uncertainties

    Defining End of Life for Medical Devices
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    Johari Digital Healthcare Ltd.

    LEMO USA Inc.

    JBC Technologies

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing

    How In Silico Simulations Can Slash Medical Device Development Risk

    The Top 7 AI Applications Transforming Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    Johari Digital Healthcare Ltd.

    LEMO USA Inc.

    JBC Technologies

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Aligning Innovation and Unmet Clinical Needs in Neuromodulation

    ...

    Aligning Innovation and Unmet Clinical Needs in Neuromodulation
    Heraeus four-by-four DBS array. Image courtesy of Heraeus Medical Components.
    Mark Hjelle, Senior Product Line Manager, Heraeus Medical Components10.16.18
    For physicians and care providers treating neurological disorders, the use of neuromodulation devices represents a potential solution for their patients.

    As this technology has evolved and advanced, its therapy applications continue to expand. With over 600 diseases of the nervous system, there is enormous opportunity for neuromodulation to play a major role as an effective treatment option to improve patients’ quality of life. This is good news for those dealing with neurological disorders such as Alzheimer’s, Parkinson’s disease, epilepsy, and chronic pain, just to name a few.

    There is no question this technology sector represents a significant and growing area. Global Market Insights projects the neurostimulation device market will exceed $16 billion by 2024. Since the beginning of this decade, the segment has experienced consistent year-to-year growth by virtually every metric, whether in reference to a specific region or globally, or by device type/therapy application. Neuromodulation is well-positioned to increase in size with a track record of helping achieve successful outcomes.

    A quick assessment of just a few of the conditions provides an overview of the scope of the market and the role neurostimulation devices can play in treatment protocols. In terms of chronic pain (such as back, spine, trunk, or limbs), its estimated prevalence is 100 million people in the United States and 1.5 billion worldwide; epilepsy affects 4.3 million in the United States and 50 million worldwide; and Parkinson’s patients number 1 million in the United States and approximately 7 million to 10 million worldwide.

    A growing market is the perfect time for OEMs to accelerate innovation. While the market is large, it is also competitive and clinically demanding. Therefore, these firms must select the right partners with which to establish a streamlined supply chain, enabling them to be agile and deliver clinically effective solutions to the market. They also require a supplier familiar with the major factors shaping, and in many cases, re-shaping this growing neuromodulation market.

    Miniaturization Is Here to Stay
    It is hard to consider miniaturization as a trend because it is actually a must-have factor that is expected in the medical profession. Therapies like neuromodulation and miniature components and devices go hand in hand. What is important for designers, engineers, and manufacturing teams to remember is that miniaturization is here to stay; devices and components will not become larger.

    Neuromodulation miniaturization, specifically, requires a holistic approach. For a device, every successive generation is on a glidepath to be smaller and more sophisticated, without sacrificing performance. In many cases, the expectation will be to also deliver greater functionality. Miniaturization success requires a team approach from all the critical disciplines: materials science, design, technology innovation, and micro manufacturing. Success requires excellence in all four of these areas.

    A New Era for Medical Technology Supply Chains
    Every change within the overall healthcare system has a ripple effect on the medical device industry. This relationship is complex, but new solutions can be developed. As a result, the industry has placed an even greater emphasis on supply chain management. In this new era of supply chain management, OEM customers are striving to streamline and simplify their supply chains in the drive to become agile in the marketplace and provide greater speed-to-market to their customers.

    What does this mean as companies work to “Lean out” their supply chains? Outsourcing is augmented by a more integrated and collaborative approach between the OEM and their supplier partners. The build-to-print model is evolving into a deeper collaboration that integrates valuable supplier innovation into the OEM’s product development cycle. This approach, called supplier-enabled innovation, has been a critical focus at Heraeus and its medical device customers; in every customer relationship, a supplier company should strive to become a natural extension of its OEM customer’s research and development team.

    Solving the Cost Versus Performance Challenge
    Every aspect of the healthcare industry—from providers to payers to distributors to manufacturers and service providers—faces the pressures of controlling escalating costs every day. From downstream to upstream, the ripple effect faces every company in this ecosystem.

    The neuromodulation segment is no different. Even the most promising or proven treatment therapies are not immune from cost pressures. Added to the mix are requests to provide greater functionality and/or improve performance. Competing in this environment requires agility and a 360-degree approach. Is there another material option that can reduce cost without sacrificing performance? Can a manufacturing process be improved? Can a new or modified design allow for additional functionality or improve the overall effectiveness of the therapy? These are the questions that should be asked—and answered—every day.

    What Does the Future Hold?
    At Heraeus, we have paid close attention to those trends and incorporated them into our strategic and operational DNA. Neuromodulation therapies have a bright future and will play an increasingly important role in treatment areas, particularly:
    • Deep Brain Stimulation (DBS)—Essential tremor, Parkinson’s disease, dystonia, epilepsy, Tourette syndrome, chronic pain, obsessive compulsive disorder, among others
    • Spinal Cord Stimulation—Chronic pain and neuropathy
    Based on past figures and future projections, neuromodulation has higher growth potential and more unmet clinical needs when compared to some other stimulation markets, such as cardiac rhythm management. Of course, in order for the industry to capitalize on this promising market, companies need to deliver the necessary innovation and device performance to enable clinicians to address those unmet needs. Fortunately, promising indicators can be observed—a high number of startups are active in this segment and large OEMs are making substantial investments.

    Whether it is an emerging startup or an established OEM, the challenges remain the same—delivering innovations to market quickly and efficiently while being clinically effective. Supplier-enabled innovation can help address both goals. To capture a share of this market, companies cannot go it alone. Supplier innovation can help OEMs avoid many of the typical challenges, roadblocks, and bottlenecks.

    The Role of University Partnerships
    There are several basic yet essential unmet clinical needs that have been identified and for which solutions are being developed—improving the precision and performance between electrodes and human tissue, and steering a therapy for increased clinical efficacy.

    For example, DBS has the potential to be a life-changing procedure for young and old alike; however, delivering effective therapy while minimizing potential harmful side effects remains a challenge. In DBS, the ability to steer the stimulation to the exact target increases the clinical efficacy of the therapy. Perhaps more importantly, this targeted therapy can minimize or eliminate potential negative side effects that can equal the impact of the original disease symptoms. The goal was to find a new way to enable more effective therapy, with more precise targeting of affected areas with fewer side effects.

    As part of Heraeus’ efforts specifically, the company established a research partnership with the University of Minnesota. Thus far, the research has indicated that increasing the segmentation of a DBS array to four electrodes per row and possibly in a four-by-four pattern may be the optimal design for DBS. High-density segmented electrode arrays could effectively address the clinical need of steering DBS therapy to a precise target. A four-by-four segmented electrode lead array could provide significant functional and performance advantages over current legacy devices. Potential benefits include:
    • Can enable a higher number of channels, connecting supplier-enabled innovations through vertical integration and miniaturization.
    • Increases the potential clinical effectiveness by providing up to 16 segmented electrodes to steer the therapy for more targeted and optimal results.
    • Has fewer components while also featuring a higher channel count, which inherently increases reliability and potentially decreases cost.
    • Is in the same form factor and size as the current market released four- and eight-channel arrays.
    • Utilizes materials and processes currently commercially approved for chronic human use in the brain, thereby eliminating any additional regulatory barriers for this innovation beyond the customer specific submission.
    Dr. Matthew Johnson, associate professor of biomedical engineering at the University of Minnesota, research partner with Heraeus, noted, “The clinical effectiveness of deep brain stimulation therapy remains strongly dependent on precisely targeting stimulation within the brain. The Heraeus four-by-four directional lead platform is a significant technological advance over existing lead designs. By improving the spatial targeting capabilities of stimulation and enabling higher-resolution electrophysiological recordings of brain activity near the site of stimulation, this new lead technology is poised to have immediate clinical impact.”

    Conclusion
    Neuromodulation has enormous potential. Like any promising treatment innovation, however, it has to prove to the medical community that it can deliver superior, safe, and cost-effective therapy when compared to current or legacy treatment options. This journey will require a re-examination and re-imagination of the traditional supply chain to a more agile and vertically integrated model. Tightly aligned internal and external collaboration will be essential to meet the shared vision of improving patients’ lives and can be achieved through supplier-enabled innovation. 


    Mark Hjelle is senior product line manager for Heraeus Medical Components.
    Related Searches
    • neuromodulation
    • figures
    • miniaturization
    • it
    Related Knowledge Center
    • Contract Manufacturing
    • Electronics
    • Neurological
    Suggested For You
    New Company Formed to Develop Peripheral Venous Disease Treatments New Company Formed to Develop Peripheral Venous Disease Treatments
    FDA Clears Eximo Medical FDA Clears Eximo Medical's B-Laser Atherectomy System to Treat Peripheral Artery Disease
    Sana Health Wins 2018 MedTech Innovator Award at The MedTech Conference Sana Health Wins 2018 MedTech Innovator Award at The MedTech Conference
    Freudenberg Offers Catheter Handle Platform and Steerable Introducer Freudenberg Offers Catheter Handle Platform and Steerable Introducer
    FDA Clears Surgical Innovation Associates FDA Clears Surgical Innovation Associates' Bioabsorbable Mesh for Reconstructive & Cosmetic Surgery
    Researchers 3D Print Prototype for Researchers 3D Print Prototype for 'Bionic Eye'
    Study: Medical Device Managers Rely on Physicians to Screen Out Defects Rather Than Issue Recalls Study: Medical Device Managers Rely on Physicians to Screen Out Defects Rather Than Issue Recalls
    PAVmed Names Chief Commercial Officer PAVmed Names Chief Commercial Officer
    Abbott Abbott's Infinity Deep Brain Stimulation System Gains MR-Conditional Labeling
    6 Proposals Receive Seed Funds to Develop Medical Devices for Children 6 Proposals Receive Seed Funds to Develop Medical Devices for Children
    20. Smith & Nephew plc 20. Smith & Nephew plc
    Surmodics Chief Financial Officer Resigns Surmodics Chief Financial Officer Resigns
    FDA Approves Glaukos FDA Approves Glaukos' iStent inject Trabecular Micro-Bypass System
    Business Leader and Political Adviser Joins BioSig Technologies Advisory Board Business Leader and Political Adviser Joins BioSig Technologies Advisory Board
    Sanford Health and Freudenberg Medical Partner to Develop Infusion System Sanford Health and Freudenberg Medical Partner to Develop Infusion System

    Related Breaking News

    • New Company Formed to Develop Peripheral Venous Disease Treatments

      New Company Formed to Develop Peripheral Venous Disease Treatments

      VeinWay received a grant from the Ideation Incentive Program of the Israel Innovation Authority.
      MEDX Xelerator 01.05.21

    • Cardiovascular | Surgical
      FDA Clears Eximo Medical

      FDA Clears Eximo Medical's B-Laser Atherectomy System to Treat Peripheral Artery Disease

      B-Laser can be used for treatment of atherectomy, infrainguinal stenoses, and occlusion, including in-stent restenosis (ISR
      Business Wire 10.08.18

    • Neurological
      Sana Health Wins 2018 MedTech Innovator Award at The MedTech Conference

      Sana Health Wins 2018 MedTech Innovator Award at The MedTech Conference

      Startup receives $350K grand prize for non-invasive neuromodulation device to treat patients with severe chronic pain.
      Business Wire 09.27.18


    • Freudenberg Offers Catheter Handle Platform and Steerable Introducer

      Freudenberg Offers Catheter Handle Platform and Steerable Introducer

      Products reflect innovative device and design solutions for accelerating time to market.
      Freudenberg Medical 09.18.18

    • Surgical
      FDA Clears Surgical Innovation Associates

      FDA Clears Surgical Innovation Associates' Bioabsorbable Mesh for Reconstructive & Cosmetic Surgery

      Much like an absorbable stitch, DuraSorb Monofilament Mesh is designed to integrate into the patient’s tissue.
      Business Wire 09.07.18

    Loading, Please Wait..

    Trending
    • Diabetes Innovation: MIT Engineers Unveil Implantable Device With Oxygen Factory
    • Medtronic Obtains EU Nod For Simplera CGM
    • A New Approach To Post-Market Surveillance
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • Hologic, Bayer Team Up For Contrast-Enhanced Mammography
    Breaking News
    • Beckman Coulter Helping Labs Comply With Annex 1 Regulation
    • FDA Clears MeMed BV Direct From Whole Blood
    • Biostrap Debuts Tool to Measure Stress Resilience, Heart Rate Variability
    • EndoTheia Announces Positive Study Results for Endoscopic Surgery Device
    • Abbott Completes Acquisition of Bigfoot Biomedical
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Releases Sustainability Report for Omega-3s Industry
    ABC’s Journal HerbalGram Celebrates 40th Anniversary
    Curcumin May Be As Effective as PPI for Indigestion
    Coatings World

    Latest Breaking News From Coatings World

    Nouryon Manufacturing Network Transitions to 100% Electricity From Renewable Sources in Brazil
    Jay Doubman Named President and CEO of ICP Group
    “MyCarbonFootprint”: BASF Launches Dashboard for Sustainable Procurement
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Beckman Coulter Helping Labs Comply With Annex 1 Regulation
    FDA Clears MeMed BV Direct From Whole Blood
    Biostrap Debuts Tool to Measure Stress Resilience, Heart Rate Variability
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Eftilagimod Cleared for Clinical Trial Use in the UK
    Veranova Names William Sanders Global VP of Chemical Development Ops
    Chime, Panolos Partner to Advance Multi-specific Therapeutic Proteins
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Hailey Bieber's Rhode Expands Into Makeup
    Avon Enters Retail Partnership with Superdrug
    IT Award Winners Announced at MakeUp in NY
    Happi

    Latest Breaking News From Happi

    Divi Expands in Stores at Ulta Beauty Tripling Footprint
    Huda Beauty Adds Easy Bake and Snatch Pressed Brightening and Setting Powder
    Detergent for Baby Bottles Contains an Odor Absorber
    Ink World

    Latest Breaking News From Ink World

    INKBANK Lays Foundation for Science and Technology Park
    Successful Labelexpo Europe 2023 Concludes in Brussels
    Recyclable, Deinkable Stand-Up Pouch Wins Gold
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Flexo Wash to exhibit at FTA Fall Technical Conference
    Recyclable, deinkable stand-up pouch wins Gold in Germany
    Elkem highlights thermal protection and battery assembly products
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Completes Work On Extra Wide Carding, Blending Line
    Ahlstrom Launches Nonwoven Laundry Care Product
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Anika Releases RevoMotion Reverse Shoulder Arthroplasty System
    Exactech's Activit-E Polyethylene OK'ed for Vantage Total Ankle
    Tyber Nets Several Regulatory Nods for K-Wires, Steinmann Pins
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    HMI Specialist RAFI Acquires Xymox Technologies Inc.
    Infineon Heads EECONE European Research Project
    NXP Honored with Prestigious Automotive Awards

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login